Suppr超能文献

印度浦那市的登革热(2017-2019 年):综合分析。

Dengue in Pune city, India (2017-2019): a comprehensive analysis.

机构信息

Department of Communicable Diseases, Interactive Research School for Health Affairs, Bharati Vidyapeeth (Deemed to be University), Pune, India.

Mankar Children Hospital, Pune, India.

出版信息

Front Public Health. 2024 Sep 20;12:1354510. doi: 10.3389/fpubh.2024.1354510. eCollection 2024.

Abstract

OBJECTIVES

To understand the dynamics of dengue disease with special reference to (1) age (2) primary/secondary infections (3) serostatus and (4) serotypes examined during three consecutive years.

METHODS

During 3 dengue seasons (2017-19), NS1/IgM ELISAs were used for dengue diagnosis in one of the 15 administrative wards of Pune City, India. Predefined symptoms were recorded at the time of diagnosis/hospitalization. IgG-capture ELISA (Panbio) was used to differentiate primary/secondary infections. DENV serotypes were determined for 260 viral RNA-positive patients.

RESULTS

During the 3 years, 3,014/6,786 (44.4%, 41.4-49.9%) suspected cases were diagnosed as dengue. Use of either NS1 or IgM would have missed 25.5% or 43% of the confirmed dengue cases, respectively. Notably, a higher proportion of secondary dengue cases remained mild while a substantial proportion of primary infections developed warning signs. The symptoms among Dengue/non-dengue patients and primary/secondary infections varied and influenced by age and serostatus. The number and proportion of dengue serotypes varied yearly. A remarkable decline in dengue cases was observed during the COVID-19 pandemic years.

CONCLUSION

A substantial proportion of primary and secondary dengue patients progress to warning signs/severity or mild infection respectively, underscoring the possible role of non-ADE mechanisms in causing severe dengue that requires hospitalization. Both NS1 and IgM should be used for efficient diagnosis.

摘要

目的

了解登革热疾病的动态,特别参考(1)年龄(2)初次/二次感染(3)血清状态和(4)连续三年检查的血清型。

方法

在三个登革热季节(2017-19 年)期间,印度浦那市的 15 个行政区之一使用 NS1/IgM ELISA 进行登革热诊断。在诊断/住院时记录了预定的症状。使用 IgG 捕获 ELISA(Panbio)来区分初次/二次感染。对 260 例病毒 RNA 阳性患者进行 DENV 血清型确定。

结果

在 3 年中,3014/6786(44.4%,41.4-49.9%)疑似病例被诊断为登革热。单独使用 NS1 或 IgM 将分别错过 25.5%或 43%的确诊登革热病例。值得注意的是,较高比例的二次登革热病例仍为轻度,而相当一部分初次感染出现了警告症状。登革热/非登革热患者以及初次/二次感染之间的症状因年龄和血清状态而异。登革热血清型的数量和比例每年都有所不同。在 COVID-19 大流行期间,登革热病例数量显著下降。

结论

相当一部分初次和二次登革热患者分别进展为警告症状/严重程度或轻度感染,这强调了非 ADE 机制在导致需要住院治疗的严重登革热中的可能作用。应同时使用 NS1 和 IgM 进行有效的诊断。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验